Journal Article

Clinical assessment incorporating a personal genome

Butte, Atul J, Hebert, Joan M, Altman, Russ B, Knowles, Joshua W, Sangkuhl, Katrin, Chou, Michael F, Neff, Norma F, Woon, Mark, Dewey, Frederick E, Wheeler, Matthew T, Greely, Henry T, Church, George M, Ashley, Euan A, Thakuria, Joseph V, Berlin, Dorit S, Rosenbaum, Abraham M, Klein, Teri E, Quake, Stephen R, Sagreiya, Hersh, Dudley, Joel T, Pavlovic, Aleksandra, Zaranek, Alexander Wait, Ormond, Kelly E, Gong, Li, Chen, Rong, Pushkarev, Dmitry, Morgan, Alexander A, Hudgins, Louanne, Thorn, Caroline F, Whaley, Ryan, Hodges, Laura M

2010

Overview

The cost of genomic information has fallen steeply, but the clinical translation of genetic risk estimates remains unclear. We aimed to undertake an integrated analysis of a complete human genome in a clinical context. We assessed a patient with a family history of vascular disease and early sudden death. Clinical assessment included analysis of this patient's full genome sequence, risk prediction for coronary artery disease, screening for causes of sudden cardiac death, and genetic counselling. Genetic analysis included the development of novel methods for the integration of whole genome and clinical risk. Disease and risk analysis focused on prediction of genetic risk of variants associated with mendelian disease, recognised drug responses, and pathogenicity for novel variants. We queried disease-specific mutation databases and pharmacogenomics databases to identify genes and mutations with known associations with disease and drug response. We estimated post-test probabilities of disease by applying likelihood ratios derived from integration of multiple common variants to age-appropriate and sex-appropriate pre-test probabilities. We also accounted for gene-environment interactions and conditionally dependent risks. Analysis of 2·6 million single nucleotide polymorphisms and 752 copy number variations showed increased genetic risk for myocardial infarction, type 2 diabetes, and some cancers. We discovered rare variants in three genes that are clinically associated with sudden cardiac death— TMEM43, DSP, and MYBPC3. A variant in LPA was consistent with a family history of coronary artery disease. The patient had a heterozygous null mutation in CYP2C19 suggesting probable clopidogrel resistance, several variants associated with a positive response to lipid-lowering therapy, and variants in CYP4F2 and VKORC1 that suggest he might have a low initial dosing requirement for warfarin. Many variants of uncertain importance were reported. Although challenges remain, our results suggest that whole-genome sequencing can yield useful and clinically relevant information for individual patients. National Institute of General Medical Sciences; National Heart, Lung And Blood Institute; National Human Genome Research Institute; Howard Hughes Medical Institute; National Library of Medicine, Lucile Packard Foundation for Children's Health; Hewlett Packard Foundation; Breetwor Family Foundation.

• Publisher: Elsevier Ltd,Elsevier,Elsevier Limited
• Subject: Adult / Aryl Hydrocarbon Hydroxylases - genetics / Biological and medical sciences / Cardiovascular disease / Carrier Proteins - genetics / Cytochrome P-450 CYP2C19 / Cytochrome P-450 Enzyme System - genetics / Cytochrome P450 Family 4 / Death, Sudden, Cardiac / Decision making / Desmoplakins - genetics / Environment / Family Health / General aspects / Genetic Counseling / Genetic Predisposition to Disease - genetics / Genetic screening / Genetic Testing / Genetics / Genome, Human / Genomics / Genotype-environment interactions / Health risks / Humans / Internal Medicine / Lipoprotein(a) - genetics / Male / Medical sciences / Membrane Proteins - genetics / Mixed Function Oxygenases - genetics / Mortality / Mutation / Myocardial infarction / Osteoarthritis - genetics / Pathogens / Pedigree / Pharmacogenetics / Polymorphism, Single Nucleotide / Risk analysis / Risk Assessment / Sequence Analysis, DNA / Vascular diseases / Vascular Diseases - genetics / Vitamin K Epoxide Reductases